The contested proxy election creates binary outcome risk: re-election of Evogene Slate signals continuity of current AI-focused strategy, while Pure Capital Slate victory introduces uncertainty without a disclosed alternative plan. Monitor proxy advisor recommendations and institutional voting patterns ahead of September 4 meeting. The reverse split authorization and share increase proposals are defensive measures to preserve Nasdaq listing but signal ongoing capital needs.
Price Chart
Executive Summary
Evogene filed proxy materials for its 2026 Annual General Meeting featuring a contested director election between the incumbent Evogene Slate (7 nominees) and the Pure Capital Slate (4 nominees) backed by 14.67% shareholders L.I.A Pure Capital and Invest-Pro. The meeting also seeks shareholder approval to increase authorized shares from 30M to 150M and authorize a reverse share split (1:2 to 1:15) to address Nasdaq minimum bid price non-compliance ($0.52 close vs $1.00 requirement). VP Business Development Olga Nissan stepped down effective July 31, 2026.
Key Facts
- Contested board election: Evogene Slate (7 nominees, including CEO Ofer Haviv) vs Pure Capital Slate (4 nominees) at September 4, 2026 meeting
- Proposal to increase authorized share capital by 120M ordinary shares (from 30M to 150M) to maintain Nasdaq compliance and strategic flexibility
- Reverse share split authorized at ratio between 1:2 and 1:15, at Board discretion within 18 months, to cure Nasdaq minimum bid price deficiency
- Nasdaq non-compliance notice received March 30, 2026; 180-day cure period expires September 28, 2026; stock closed at $0.52 on July 27, 2026
- VP Business Development Olga Nissan stepped down effective July 31, 2026; search for replacement underway
- Board reports headcount reduced from ~117 to 39 employees (67% reduction), cash burn lowered from ~$20.5M (2024) to ~$8.5-9.5M (2026 est.)
- Company raised ~$14.2M in new capital and generated ~$15.25M from Lavie Bio sale to ICL
Financial Impact
Authorized share increase of 120M shares (400% expansion) creates potential for significant future dilution; reverse split ratio up to 1:15 will mechanically reduce share count but no proportional price increase guaranteed
Risk Factors
- Dissident slate victory could disrupt strategic momentum and partner relationships
- Reverse split may not achieve sustained Nasdaq compliance if share price continues to decline
- Authorized share increase enables substantial future dilution without further shareholder vote
- Tiny $6M market cap amplifies price sensitivity to any binary outcome
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001178913-26-003741 |
| Exhibit: exhibit_99-4.htm | 0001178913-26-003741 |
| Exhibit: exhibit_99-1.htm | 0001178913-26-003741 |
| Exhibit: exhibit_99-3.htm | 0001178913-26-003741 |
| Document: zk2635808.htm | 0001178913-26-003741 |
| Document: 0001178913-26-003741-index-headers.html | 0001178913-26-003741 |
| Document: 0001178913-26-003741-index.html | 0001178913-26-003741 |
| Document: 0001178913-26-003741.txt | 0001178913-26-003741 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 22, 2026 4d ago | 3 | $0.3641 | awaiting T+60 | — | $0.3700 (+1.62%) |
Oct 6, 2026 20d ago | SC 13D/A | $0.4106 | awaiting T+60 | — | $0.3700 (−9.89%) |
Oct 6, 2026 20d ago | 6-K | $0.4106 | awaiting T+60 | — | $0.3700 (−9.89%) |
Sep 30, 2026 26d ago | 6-K | $0.4000 | awaiting T+60 | — | $0.3700 (+7.50%) |
Sep 30, 2026 27d ago | EFFECT | $0.4000 | awaiting T+60 | — | $0.3700 (+7.50%) |
Sep 4, 2026 7w ago | 6-K | $0.5379 | awaiting T+60 | — | $0.3700 (−31.21%) |
Aug 18, 2026 9w ago | 6-K | $0.5826 | awaiting T+60 | — | $0.3700 (−36.49%) |
Aug 14, 2026 10w ago | Press Release | $0.6008 | awaiting T+60 | — | $0.3700 (−38.42%) |
Jul 31, 2026 12w ago | 6-K | $0.5400 | awaiting T+60 | — | $0.3700 (−31.48%) |
Jun 16, 2026 18w ago | 6-K | $0.5600 $0.4806 | ▼ −14.18% | ▼ −15.18% | $0.3700 (−33.93%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers